The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster
Open accessAbstract
SUMMARY The primary varicella zoster virus (VZV) infection results in chickenpox (varicella), which is transmitted via the airborne route. VZV is highly infectious, but in the USA the incidence of varicella has been reduced by 76–87% as a result of the varicella vaccine. The virus establishes latency in the dorsal root ganglia during varicella and, when reactivated, travels along the sensory nerve axons to cause shingles (herpes zoster [HZ]). There are over 1 million cases of HZ in the USA each year, with an estimated lifetime attack rate of 30%. The incidence of HZ, which causes significant morbidity, increases with age and reaches approximately 10 cases per 1,000 patient-years by age 80. Cell-mediated immunity (CMI) is known to decline with age as part of immunosenescence, and decreased CMI is associated with reactivation of VZV. This article provides an overview of our emerging understanding of the epidemiology and pathogenesis of varicella and HZ, in addition to exploring the current theories on latency and reactivation. Understanding the risk factors for developing HZ and the complications associated with infection, particularly in older people, is important for prompt diagnosis and management of HZ in primary care, and they are therefore also reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
The Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.15.1605 · Cited by 652
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
What does epidemiology tell us about risk factors for herpes zoster?
Thomas, S. L., & Hall, A. J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00857-0 · Cited by 561
The incidence of herpes zoster in a United States administrative database
Insinga, R. P., Itzler, R. F., Pellissier, J. M., Saddier, P., & Nikas, A. A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0150.x · Cited by 490
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
BRISSON, M., EDMUNDS, W. J., LAW, B., GAY, N. J., WALLD, R., BROWNELL, M., ROOS, L. L., & DE SERRES, G. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801005921 · Cited by 432
Use of an Inactivated Varicella Vaccine in Recipients of Hematopoietic-Cell Transplants
Hata, A., Asanuma, H., Rinki, M., Sharp, M., Wong, R. M., Blume, K., & Arvin, A. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013441 · Cited by 300
Immune Responses to Varicella-Zoster in the Aged
Burke, B. L. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340150091017 · Cited by 295
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
GAUTHIER, A., BREUER, J., CARRINGTON, D., MARTIN, M., & RÉMY, V. (2009) · Epidemiology and Infection · doi:10.1017/s0950268808000678 · Cited by 287
Self-citationHerpes zoster: Epidemiology, natural history, and common complications
Weinberg, J. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.046 · Cited by 278
Cited by
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501184 · Cited by 1,454
Self-citationGalectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
Wang, N., Chen, M., & Wang, T. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.025 · Cited by 308
Chlibek, R., Bayas, J. M., Collins, H., de la Pinta, M. L. R., Ledent, E., Mols, J. F., & Heineman, T. C. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit365 · Cited by 149
Leroux-Roels, I., Leroux-Roels, G., Clement, F., Vandepapelière, P., Vassilev, V., Ledent, E., & Heineman, T. C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis497 · Cited by 147
Metadata
- Authors
- Gershon, A. A., Gershon, M. D., Breuer, J., Levin, M. J., Oaklander, A. L., & Griffiths, P. D.
- Venue
- Journal of Clinical Virology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 48
- Pages
- S2-S7
- ISSN
- 1386-6532 (ISSN-L)
- OpenAlex
- W1996563874
- Cited by
- 313
- References
- 36
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. https://app.cochat.ai/papers/10.1016/s1386-6532(10)70002-0
- The paper
- Gershon, A. A., Gershon, M. D., Breuer, J., Levin, M. J., Oaklander, A. L., & Griffiths, P. D. (2010). Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. Journal of Clinical Virology. https://doi.org/10.1016/s1386-6532(10)70002-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.